ArticleScientific reports2025
Genomic data mining reveals hub genes and lncRNAs as prognostic biomarkers in breast cancer.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer is a complex disease that is characterized by altered functions of many genes. In this study, we aim to establish long non-coding RNAs as prognostic biomarkers as they play vital roles in their prognosis and progression. For this purpose, we retrieved four datasets (GSE10810, GSE42568, GSE65194, and GSE45827) from NCBI Gene Expression Omnibus. Using R studio, we identified differentially expressed genes followed by functional enrichment analysis with the help of DAVID software. DEGs were used to construct a protein-protein interaction map which we later used to identify highly correlated genes with the help of sub-network identification and centrality analysis in cytoscape software. Next, lncRNAs-mRNA coexpression analysis was performed to determine the potential role of lncRNAs. Later on, we assessed their role in survival with the help of Kaplein Meir's plot. The results of these analyses establish long noncoding RNAs i.e. EPB41L4A-AS1, LINC00667, MAGI2-AS3, and MALAT1 as prognostic biomarkers. This study provides a blueprint for identifying mRNA-lncRNA networks in any cancer, facilitating the use of lncRNAs as prognostic biomarkers and aiding in the identification of therapeutic targets. Future research may focus on validating this research biologically to further substantiate the role of lncRNAs as prognostic biomarkers in breast cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.